nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—MMP12—Collagen degradation—COL18A1—sarcoma	0.162	0.244	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—COL18A1—sarcoma	0.0821	0.124	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PDGFRB—sarcoma	0.0632	0.0951	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP2—sarcoma	0.0559	0.0842	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP2—sarcoma	0.0463	0.0697	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—COL18A1—sarcoma	0.0344	0.0518	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—sarcoma	0.0296	0.0446	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—sarcoma	0.026	0.0391	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP2—sarcoma	0.0234	0.0353	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL2—sarcoma	0.0149	0.0223	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCND1—sarcoma	0.0145	0.0218	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CCND1—sarcoma	0.0132	0.0199	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—JUN—sarcoma	0.0132	0.0199	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—KDR—sarcoma	0.012	0.0181	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SRC—sarcoma	0.0118	0.0178	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MYC—sarcoma	0.0116	0.0175	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—EGFR—sarcoma	0.0114	0.0171	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MYC—sarcoma	0.0106	0.016	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP2—sarcoma	0.00982	0.0148	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TP53—sarcoma	0.00954	0.0144	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TP53—sarcoma	0.00872	0.0131	CbGpPWpGaD
Acetohydroxamic Acid—Lethargy—Dactinomycin—sarcoma	0.00793	0.0237	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Thiotepa—sarcoma	0.00593	0.0177	CcSEcCtD
Acetohydroxamic Acid—Feeling hot—Epirubicin—sarcoma	0.00554	0.0165	CcSEcCtD
Acetohydroxamic Acid—Depression—Vincristine—sarcoma	0.00534	0.0159	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Mitoxantrone—sarcoma	0.00512	0.0153	CcSEcCtD
Acetohydroxamic Acid—Feeling hot—Doxorubicin—sarcoma	0.00512	0.0153	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Thiotepa—sarcoma	0.00479	0.0143	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Dactinomycin—sarcoma	0.00475	0.0142	CcSEcCtD
Acetohydroxamic Acid—Tension—Thiotepa—sarcoma	0.00463	0.0138	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Thiotepa—sarcoma	0.00458	0.0137	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Thiotepa—sarcoma	0.00436	0.013	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Dactinomycin—sarcoma	0.00434	0.013	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Dactinomycin—sarcoma	0.00433	0.0129	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Etoposide—sarcoma	0.00426	0.0127	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Vincristine—sarcoma	0.00425	0.0127	CcSEcCtD
Acetohydroxamic Acid—Malaise—Dactinomycin—sarcoma	0.00422	0.0126	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Mitoxantrone—sarcoma	0.00414	0.0123	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Thiotepa—sarcoma	0.004	0.0119	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Dactinomycin—sarcoma	0.00394	0.0117	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Vincristine—sarcoma	0.00387	0.0115	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Mitoxantrone—sarcoma	0.00378	0.0113	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Mitoxantrone—sarcoma	0.00377	0.0112	CcSEcCtD
Acetohydroxamic Acid—Malaise—Mitoxantrone—sarcoma	0.00367	0.011	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Thiotepa—sarcoma	0.00367	0.0109	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Epirubicin—sarcoma	0.00364	0.0109	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Dactinomycin—sarcoma	0.00364	0.0109	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Mitoxantrone—sarcoma	0.00346	0.0103	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Etoposide—sarcoma	0.00344	0.0103	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Mitoxantrone—sarcoma	0.00343	0.0102	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Doxorubicin—sarcoma	0.00337	0.0101	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Thiotepa—sarcoma	0.00335	0.00998	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Thiotepa—sarcoma	0.00332	0.00991	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Dactinomycin—sarcoma	0.00332	0.00991	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Thiotepa—sarcoma	0.00332	0.0099	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Epirubicin—sarcoma	0.00331	0.00988	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Dactinomycin—sarcoma	0.00329	0.00982	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Vincristine—sarcoma	0.00325	0.0097	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Epirubicin—sarcoma	0.00322	0.0096	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Thiotepa—sarcoma	0.00317	0.00946	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Mitoxantrone—sarcoma	0.00317	0.00945	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Dactinomycin—sarcoma	0.00315	0.00939	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Etoposide—sarcoma	0.00314	0.00938	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Etoposide—sarcoma	0.00313	0.00934	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Doxorubicin—sarcoma	0.00307	0.00914	CcSEcCtD
Acetohydroxamic Acid—Malaise—Etoposide—sarcoma	0.00306	0.00911	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Doxorubicin—sarcoma	0.00298	0.00888	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vincristine—sarcoma	0.00297	0.00885	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Vincristine—sarcoma	0.00295	0.00879	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Vincristine—sarcoma	0.00294	0.00878	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Mitoxantrone—sarcoma	0.00289	0.00862	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Mitoxantrone—sarcoma	0.00287	0.00855	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Etoposide—sarcoma	0.00285	0.0085	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Thiotepa—sarcoma	0.00276	0.00824	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Dactinomycin—sarcoma	0.00274	0.00818	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Mitoxantrone—sarcoma	0.00274	0.00817	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Etoposide—sarcoma	0.00264	0.00786	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vincristine—sarcoma	0.00245	0.0073	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Thiotepa—sarcoma	0.00245	0.0073	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Dactinomycin—sarcoma	0.00243	0.00725	CcSEcCtD
Acetohydroxamic Acid—Rash—Thiotepa—sarcoma	0.00243	0.00724	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Thiotepa—sarcoma	0.00243	0.00723	CcSEcCtD
Acetohydroxamic Acid—Headache—Thiotepa—sarcoma	0.00241	0.00719	CcSEcCtD
Acetohydroxamic Acid—Rash—Dactinomycin—sarcoma	0.00241	0.00718	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Etoposide—sarcoma	0.0024	0.00717	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Epirubicin—sarcoma	0.00239	0.00713	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Etoposide—sarcoma	0.00239	0.00712	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Mitoxantrone—sarcoma	0.00239	0.00711	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Etoposide—sarcoma	0.00238	0.00711	CcSEcCtD
Acetohydroxamic Acid—Nausea—Thiotepa—sarcoma	0.00229	0.00682	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Etoposide—sarcoma	0.00228	0.0068	CcSEcCtD
Acetohydroxamic Acid—Nausea—Dactinomycin—sarcoma	0.00227	0.00677	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Doxorubicin—sarcoma	0.00221	0.00659	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vincristine—sarcoma	0.00217	0.00647	CcSEcCtD
Acetohydroxamic Acid—Rash—Vincristine—sarcoma	0.00215	0.00642	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vincristine—sarcoma	0.00215	0.00641	CcSEcCtD
Acetohydroxamic Acid—Headache—Vincristine—sarcoma	0.00214	0.00638	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Mitoxantrone—sarcoma	0.00211	0.0063	CcSEcCtD
Acetohydroxamic Acid—Rash—Mitoxantrone—sarcoma	0.0021	0.00625	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Mitoxantrone—sarcoma	0.00209	0.00625	CcSEcCtD
Acetohydroxamic Acid—Headache—Mitoxantrone—sarcoma	0.00208	0.00621	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vincristine—sarcoma	0.00203	0.00605	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Etoposide—sarcoma	0.00198	0.00592	CcSEcCtD
Acetohydroxamic Acid—Nausea—Mitoxantrone—sarcoma	0.00198	0.00589	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Epirubicin—sarcoma	0.00193	0.00575	CcSEcCtD
Acetohydroxamic Acid—Tension—Epirubicin—sarcoma	0.00186	0.00556	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Epirubicin—sarcoma	0.00184	0.0055	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Doxorubicin—sarcoma	0.00178	0.00532	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Epirubicin—sarcoma	0.00176	0.00526	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Etoposide—sarcoma	0.00176	0.00524	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Epirubicin—sarcoma	0.00176	0.00524	CcSEcCtD
Acetohydroxamic Acid—Rash—Etoposide—sarcoma	0.00174	0.0052	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Etoposide—sarcoma	0.00174	0.0052	CcSEcCtD
Acetohydroxamic Acid—Headache—Etoposide—sarcoma	0.00173	0.00517	CcSEcCtD
Acetohydroxamic Acid—Tension—Doxorubicin—sarcoma	0.00172	0.00514	CcSEcCtD
Acetohydroxamic Acid—Malaise—Epirubicin—sarcoma	0.00171	0.00511	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Doxorubicin—sarcoma	0.00171	0.00509	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Epirubicin—sarcoma	0.00168	0.00501	CcSEcCtD
Acetohydroxamic Acid—Nausea—Etoposide—sarcoma	0.00164	0.0049	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Doxorubicin—sarcoma	0.00163	0.00486	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Doxorubicin—sarcoma	0.00162	0.00484	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Epirubicin—sarcoma	0.00161	0.00481	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Epirubicin—sarcoma	0.0016	0.00476	CcSEcCtD
Acetohydroxamic Acid—Malaise—Doxorubicin—sarcoma	0.00159	0.00473	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Doxorubicin—sarcoma	0.00155	0.00463	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Doxorubicin—sarcoma	0.00149	0.00445	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Doxorubicin—sarcoma	0.00148	0.00441	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Epirubicin—sarcoma	0.00148	0.00441	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Doxorubicin—sarcoma	0.00137	0.00408	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Epirubicin—sarcoma	0.00135	0.00402	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Epirubicin—sarcoma	0.00134	0.00399	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Epirubicin—sarcoma	0.00134	0.00399	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Epirubicin—sarcoma	0.00128	0.00381	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Doxorubicin—sarcoma	0.00125	0.00372	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00124	0.00369	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Doxorubicin—sarcoma	0.00124	0.00369	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Doxorubicin—sarcoma	0.00118	0.00352	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Epirubicin—sarcoma	0.00111	0.00332	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Doxorubicin—sarcoma	0.00103	0.00307	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Epirubicin—sarcoma	0.000986	0.00294	CcSEcCtD
Acetohydroxamic Acid—Rash—Epirubicin—sarcoma	0.000978	0.00291	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Epirubicin—sarcoma	0.000977	0.00291	CcSEcCtD
Acetohydroxamic Acid—Headache—Epirubicin—sarcoma	0.000971	0.0029	CcSEcCtD
Acetohydroxamic Acid—Nausea—Epirubicin—sarcoma	0.000921	0.00275	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Doxorubicin—sarcoma	0.000912	0.00272	CcSEcCtD
Acetohydroxamic Acid—Rash—Doxorubicin—sarcoma	0.000904	0.0027	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Doxorubicin—sarcoma	0.000904	0.00269	CcSEcCtD
Acetohydroxamic Acid—Headache—Doxorubicin—sarcoma	0.000899	0.00268	CcSEcCtD
Acetohydroxamic Acid—Nausea—Doxorubicin—sarcoma	0.000852	0.00254	CcSEcCtD
